GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Indo US Bio-Tech Ltd (BOM:541304) » Definitions » Net Income (Continuing Operations)

Indo US Bio-Tech (BOM:541304) Net Income (Continuing Operations) : ₹50.6 Mil (TTM As of Mar. 2022)


View and export this data going back to 2018. Start your Free Trial

What is Indo US Bio-Tech Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Indo US Bio-Tech's Net Income (Continuing Operations) for the six months ended in Mar. 2022 was ₹26.0 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2022 was ₹50.6 Mil.


Indo US Bio-Tech Net Income (Continuing Operations) Historical Data

The historical data trend for Indo US Bio-Tech's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo US Bio-Tech Net Income (Continuing Operations) Chart

Indo US Bio-Tech Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.49 20.88 25.35 49.00 50.63

Indo US Bio-Tech Semi-Annual Data
Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.23 14.82 34.18 24.63 26.01

Indo US Bio-Tech Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹50.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indo US Bio-Tech  (BOM:541304) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


Indo US Bio-Tech Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Indo US Bio-Tech's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


Indo US Bio-Tech (BOM:541304) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Satadhar Char Rasta, Sola Road, 309, Shanti Mall, Opposite Navrang Tower, Ahmedabad, GJ, IND, 380061
Indo US Bio-Tech Ltd is engaged in the trading of agricultural seeds. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of agriculture crops. The company's product categories include vegetables; cotton seeds; oilseeds; spices seeds; pulses seeds and cereals seeds.

Indo US Bio-Tech (BOM:541304) Headlines

No Headlines